Linagliptin plus metformin combination was as effective at lowering hemoglobin A1c as glimepiride plus metformin, and with weight loss and less hypoglycemia SAN DIEGO, June 24, 2011 /PRNewswire/ -- ...
INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--EX US, UK and UAE Medical Media Only. Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced results of a 24-week open label arm ...
In Korean adults with type 2 diabetes, combination sitagliptin and metformin as first-line therapy showed a greater improvement in glycemic control and fasting plasma glucose at 30 weeks vs.
June 11, 2012 (Philadelphia, Pennsylvania) — In patients whose diabetes is not controlled with metformin, the addition of exenatide might be a better option than the sulfonylurea glimepiride, ...
A recently published study examined the effects of adding sitagliptin—an inhibitor of dipeptidyl peptidase 4—to therapy for patients with type 2 diabetes mellitus who were inadequately controlled on ...
Glimepiride oral tablet is available as a generic drug and as a brand-name drug. Brand name: Amaryl. Glimepiride comes as a tablet you take by mouth. Glimepiride is used to treat type 2 diabetes. It ...
Boehringer Ingelheim and Lilly today announced Phase III study results for linagliptin, demonstrating improved glycemic control in adults with type 2 diabetes (T2D) whose blood glucose is not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results